# Darren Schulte

> Darren Schulte, MD, MPP, is the CEO of Vynca and a physician-executive whose career has moved from clinical quality measurement to healthcare analytics, artificial intelligence, and technology-enabled care delivery. After leading Apixio for six years through its 2020 acquisition by Centene and serving as Centene's chief innovation officer, he joined Vynca in 2023 to scale a model that combines software, predictive data, and interdisciplinary teams.

- **Role:** Chief Executive Officer at Vynca
- **Organizations:** Vynca, Centene Corporation, Apixio, Anvita Health, Alere, Resolution Health, UCSF Health, National Committee for Quality Assurance
- **Education:** B.S., University of California, Berkeley, M.D., Stanford University School of Medicine, Master of Public Policy (M.P.P.), Harvard Kennedy School, Internal medicine training, University of California, San Francisco
- **Known for:** Led Apixio for six years through its acquisition by Centene in late 2020., Co-developed 25 clinical measures endorsed by the National Quality Forum for ambulatory care quality measurement using electronic data., Co-inventor of six U.S. patents, according to Vynca's 2023 appointment announcement.

## Career timeline

- **2002-2004** — Trained as a resident physician in internal medicine at UCSF.
- **2004-2009** — Served as Director of Clinical Affairs and Analytics at Resolution Health.
- **2009-2010** — Held senior clinical innovation and collaborative care roles at Alere.
- **2010-2011** — Served as Vice President of Clinical Strategy at Anvita Health.
- **2011-2014** — Joined Apixio as Chief Medical Officer, later becoming President and Chief Medical Officer.
- **2014-2020** — Led Apixio as Chief Executive Officer until its acquisition by Centene in late 2020.
- **2020-2022** — Led advanced technology and later served as Chief Innovation Officer at Centene.
- **2023-present** — Appointed Chief Executive Officer and board director of Vynca.

## Achievements

- Led Apixio for six years through its acquisition by Centene in late 2020.
- Co-developed 25 clinical measures endorsed by the National Quality Forum for ambulatory care quality measurement using electronic data.
- Co-inventor of six U.S. patents, according to Vynca's 2023 appointment announcement.
- Served on the National Committee for Quality Assurance Committee for Performance Measurement.
- Named to The Healthcare Technology Report's Top 50 Healthcare Technology CEOs of 2020 list.
- Became CEO and a board director of Vynca in June 2023.

## Latest updates

- **2026-06** — Published 'Dying Without a Safety Net' in MedCity News, arguing for a coordinated serious-illness operating system and funding models that reward earlier intervention.
- **2026-03** — Discussed clinician burnout, care coordination, and workforce sustainability with Hospice News.
- **2026-02** — Announced Jill Schwartz-Chevlin as Vynca's chief medical officer as the company expanded its clinical leadership.
- **2025-07** — Discussed predictive analytics, remote monitoring, reimbursement, and outpatient access at the Hospice ELEVATE conference.
- **2025-05** — Outlined the operational and reimbursement requirements for sustaining standalone palliative-care organizations in Palliative Care News.

## Links

- Website: https://www.vyncacare.com
- LinkedIn: https://www.linkedin.com/in/darrenschultemd

---

Profile page: https://yespress.io/darren-schulte
Published by YesPress — https://yespress.io
Last updated: 2026-08-18